发明名称 |
Melanoma antigens |
摘要 |
<p>The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognose a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma.</p> |
申请公布号 |
EP1630229(B1) |
申请公布日期 |
2013.04.03 |
申请号 |
EP20050018103 |
申请日期 |
1995.04.21 |
申请人 |
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMANSERVICES |
发明人 |
KAWAKAMI, YUTAKA;ROSENBERG, STEVEN A. |
分类号 |
A01K67/027;C12N15/12;A61K38/00;A61K38/17;A61K39/00;A61K39/395;A61P35/00;A61P37/04;C07K14/47;C07K14/82;C07K16/18;C07K16/32;C12N5/10;C12N15/09;C12P21/02;C12P21/08;C12Q1/68;G01N33/53;G01N33/574;G01N33/577 |
主分类号 |
A01K67/027 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|